Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

2018299 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Respiratory Medicine

Volume 7, Issue 1, pp. 46-59

Field-Weighted Citation Impact: 18.71